Residency · Residency · Internal Medicine

Hypertensive Emergencies and Urgencies

Pathophysiology

Hypertensive Emergency

A hypertensive emergency occurs when severe blood pressure elevation (typically above 180/120 mmHg) causes acute end-organ damage. The key concept is that it is the presence of end-organ damage, not the absolute blood pressure number, that defines the emergency. When cerebral autoregulation fails, cerebral edema develops (hypertensive encephalopathy). Endothelial damage triggers fibrinoid necrosis of arterioles, microangiopathic hemolysis, and activation of the coagulation cascade. RAAS activation and pressure natriuresis create a vicious cycle of volume depletion and further vasoconstriction.

Hypertensive Urgency

Hypertensive urgency involves severe blood pressure elevation without acute end-organ damage. It is often related to medication non-adherence, pain, anxiety, or medication interactions and does not require IV therapy or ICU admission in most cases.

End-Organ Damage Targets

The brain may develop hypertensive encephalopathy, ischemic or hemorrhagic stroke, or posterior reversible encephalopathy syndrome (PRES). The heart can suffer acute heart failure with pulmonary edema, acute coronary syndrome, or aortic dissection. The kidneys sustain acute injury with hematuria and proteinuria. The eyes may show papilledema, retinal hemorrhages, and exudates. Vascular damage includes aortic dissection and microangiopathic hemolytic anemia. In pregnancy, eclampsia and HELLP syndrome are the feared complications.

Clinical Presentation

Hypertensive Emergency Syndromes

Hypertensive encephalopathy presents with headache, confusion, visual disturbance, nausea, vomiting, and seizures; it is a diagnosis of exclusion after stroke has been ruled out. Acute aortic dissection produces tearing chest or back pain with blood pressure differential between arms and a widened mediastinum. Acute pulmonary edema causes dyspnea, orthopnea, rales, an S3 gallop, and hypoxia. ACS manifests with chest pain, ECG changes, and troponin elevation. Acute kidney injury results in oliguria, rising creatinine, and hematuria. Eclampsia or preeclampsia with severe features includes seizures, headache, visual changes, proteinuria, thrombocytopenia, and elevated liver function tests. Malignant hypertension with microangiopathy shows schistocytes on blood smear, elevated LDH, low haptoglobin, and thrombocytopenia.

History Red Flags

Important historical clues include medication non-adherence or recent discontinuation (particularly clonidine rebound), sympathomimetic drug use (cocaine, amphetamines), pregnancy or postpartum state, and known pheochromocytoma or other secondary causes.

Diagnostic Workup

Initial Assessment

Blood pressure must be confirmed with proper technique: appropriate cuff size, patient seated for five minutes, and measured in both arms (to screen for aortic dissection). A fundoscopic examination should look for papilledema, flame hemorrhages, cotton-wool spots, and hard exudates. A thorough neurologic exam assesses mental status and focal deficits.

Laboratory Studies

The initial workup includes a basic metabolic panel (creatinine and electrolytes -- hypokalemia suggests a secondary cause), CBC with peripheral smear (schistocytes suggest thrombotic microangiopathy), urinalysis (proteinuria, hematuria, RBC casts), troponin, and BNP or NT-proBNP if dyspnea is present. LDH, haptoglobin, and reticulocyte count are obtained when microangiopathy is suspected. A urine drug screen for cocaine and amphetamines and a pregnancy test in reproductive-age women should be considered.

Imaging

An ECG may reveal LVH, ischemia, or a strain pattern. A chest X-ray can show pulmonary edema or a widened mediastinum. CT or CTA is indicated when aortic dissection or stroke is suspected. CT or MRI of the brain is warranted for encephalopathy or focal neurologic deficits.

Management

General Principles for Hypertensive Emergency

Patients require ICU admission with continuous arterial blood pressure monitoring, preferably via an arterial line. Intravenous antihypertensive therapy is standard. The target is to reduce mean arterial pressure by no more than 25 percent in the first hour, then to approximately 160/100 over the next two to six hours, followed by gradual normalization over 24 to 48 hours. Overly rapid reduction risks watershed infarction in the brain, kidneys, and coronary circulation -- this risk is especially pronounced in chronically hypertensive patients whose autoregulatory curve has shifted rightward.

IV Antihypertensive Agents

AgentMechanismOnsetPreferred Setting
NicardipineCCB5-10 minMost emergencies; easy to titrate
ClevidipineCCB1-2 minUltra-short acting; excellent titrability
LabetalolAlpha/beta blocker5-10 minMost emergencies; avoid in acute HF, asthma, cocaine
NitroprussideNO donorImmediateRefractory cases; risk of cyanide toxicity
NitroglycerinVenodilator1-2 minACS, acute pulmonary edema
EsmololBeta-1 blocker1-2 minAortic dissection (rate control); peri-op
FenoldopamDA-1 agonist5-10 minAKI (preserves renal perfusion)
HydralazineArteriolar vasodilator10-30 minPregnancy (eclampsia); unpredictable response
PhentolamineAlpha blocker1-2 minPheochromocytoma crisis, cocaine-induced

Specific Scenarios

Aortic Dissection

This is the one scenario demanding the most aggressive blood pressure lowering: target SBP below 120 mmHg and heart rate below 60 bpm within 20 minutes. An IV beta-blocker (esmolol) must be started first to prevent reflex tachycardia, and then nicardipine or nitroprusside can be added. Pure vasodilators such as hydralazine or nitroprusside given alone without beta-blockade are dangerous because reflex tachycardia increases aortic shear stress.

Acute Pulmonary Edema

IV nitroglycerin is the primary vasodilator, reducing preload. An IV loop diuretic is given concurrently, with nicardipine as an alternative. Labetalol should be avoided in acute decompensated heart failure because of its negative inotropic effects. Non-invasive ventilation (BiPAP or CPAP) provides respiratory support.

Acute Ischemic Stroke

If the patient is a thrombolysis candidate, blood pressure should be lowered to below 185/110 before tPA and maintained below 180/105 for 24 hours afterward. If thrombolysis is not planned, permissive hypertension is the approach -- treatment is indicated only if blood pressure exceeds 220/120. Nicardipine or labetalol are the preferred agents.

Cocaine-Induced Hypertensive Emergency

Benzodiazepines are first-line to reduce sympathetic drive. For persistent hypertension, phentolamine or nicardipine is added. Beta-blockers (including labetalol) are traditionally avoided because of the risk of unopposed alpha-mediated vasoconstriction, though this dogma is increasingly debated. Nitroglycerin is appropriate if ACS is present.

Eclampsia/Preeclampsia with Severe Features

IV labetalol or IV hydralazine (both with extensive experience in pregnancy) are the primary agents, with nicardipine as an alternative. Magnesium sulfate is essential for seizure prophylaxis and treatment. Delivery is the definitive treatment. ACE inhibitors, ARBs, and nitroprusside are contraindicated because of teratogenic or toxic effects.

Pheochromocytoma Crisis

Alpha-blockade must come first -- IV phentolamine is the agent of choice. Beta-blockers should be added only after adequate alpha-blockade is established, as giving beta-blockers first can precipitate a hypertensive crisis from unopposed alpha stimulation. Nicardipine is an alternative.

Hypertensive Urgency Management

Oral agents are preferred. Home antihypertensives should be restarted, with options including clonidine 0.1-0.2 mg PO, captopril 25 mg PO, or amlodipine. Sublingual nifedipine must be avoided because it causes unpredictable and dangerous blood pressure drops. Close outpatient follow-up within 24 to 72 hours is essential, along with attention to non-adherence, medication access, and underlying causes.

Secondary Hypertension Screening

Secondary causes should be considered in young patients (under 30), resistant hypertension, acute-onset or worsening hypertension, hypokalemia, or medication-refractory cases. The workup includes renal artery duplex, MRA, or CTA for renovascular disease; aldosterone-to-renin ratio for primary aldosteronism (the most common secondary cause); plasma free metanephrines for pheochromocytoma; 24-hour urine cortisol or overnight dexamethasone suppression test for Cushing syndrome; blood pressure differential between upper and lower extremities for coarctation of the aorta; TSH for thyroid disease; and screening questionnaire with sleep study for obstructive sleep apnea.

<image> A medical illustration showing the cerebral autoregulation curve. Plot cerebral blood flow (y-axis) against mean arterial pressure (x-axis, 0-200 mmHg). Show the normal autoregulatory plateau between MAP 60-150 mmHg as a flat portion of the curve. Display a second curve shifted to the right for chronic hypertension (plateau from MAP 80-180). Mark the danger zones: below the lower limit (cerebral ischemia/watershed infarction from too-rapid BP lowering) and above the upper limit (breakthrough cerebral edema/hypertensive encephalopathy). Use arrows to indicate the target 25% MAP reduction in the first hour. Clean line graph with clear labels and annotations. </image>

<image> A fundoscopic photograph illustration showing four quadrants of hypertensive retinopathy grades. Top-left (Grade I): arteriolar narrowing and mild AV nicking. Top-right (Grade II): more pronounced AV nicking with copper-wire arterioles. Bottom-left (Grade III): flame-shaped hemorrhages, cotton-wool spots, and hard exudates. Bottom-right (Grade IV): all previous findings plus papilledema with disc swelling. Each quadrant labeled with the grade and key findings. Realistic ophthalmoscopic appearance with orange-red retinal background and clearly visible vessels. </image>

<image> A table-style infographic comparing IV antihypertensive agents for hypertensive emergencies. Organize as a visual reference card with columns for: drug name, mechanism, onset of action, duration, dose range, preferred clinical scenario, and key cautions. Include nicardipine, clevidipine, labetalol, nitroprusside, nitroglycerin, esmolol, fenoldopam, hydralazine, and phentolamine. Use color-coded rows grouping by drug class (CCBs in blue, beta-blockers in green, vasodilators in red, alpha-blockers in purple). Clean medical reference style. </image>

Clinical Pearls

Hypertensive emergency is defined by the presence of end-organ damage, not by an absolute blood pressure threshold -- the clinical assessment for target organ involvement is what matters. The most common mistake is lowering blood pressure too rapidly; the target is a 25 percent MAP reduction in the first hour to avoid watershed ischemia. Aortic dissection is the exception that demands rapid and aggressive lowering to SBP below 120 within minutes, with a beta-blocker always given before any vasodilator. Sublingual nifedipine should never be used because uncontrollable blood pressure drops cause strokes and myocardial infarctions. Asymptomatic severe hypertension (urgency) rarely requires emergency department admission; the focus should be on restarting medications, ensuring follow-up, and addressing adherence. A peripheral blood smear should always be checked in severe hypertension because schistocytes indicate thrombotic microangiopathy. Clonidine withdrawal can cause rebound hypertensive crisis, so clonidine should be reinstituted if this is suspected. In cocaine-associated hypertensive emergency, benzodiazepines are first-line while beta-blockers are traditionally contraindicated, though the evidence is evolving. A fundoscopic exam must always be performed because papilledema upgrades an urgency to an emergency.

References

  • Whelton PK, et al. 2017 ACC/AHA Guideline for HTN. J Am Coll Cardiol. 2018.
  • van den Born BH, et al. ESC Council on Hypertension Position Document on Management of Hypertensive Emergencies. Eur Heart J Cardiovasc Pharmacother. 2019.
  • SPRINT Trial: Wright JT, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. NEJM. 2015.
  • Peixoto AJ. Acute Severe Hypertension. NEJM. 2019.
  • Saguner AM, et al. Management of Hypertensive Emergencies. Swiss Med Wkly. 2019.
Hypertensive Emergencies and Urgencies — figure 1
Hypertensive Emergencies and Urgencies — figure 2
Hypertensive Emergencies and Urgencies — figure 3

Read this lecture as Markdown